同济mba商务英语考题

《商务英语》试卷(A卷)
（2014～2015学年第二学期）
任课教师：考试形式：开卷（）闭卷（√）使用电脑：允许（）不允许（√）班级：学号：姓名：
试题编号I II III 总分
得分
I．Essay Questions (40%)
Directions: Give a brief answer to each of the following questions. Remember to apply what you have learned in the coursework.
1. What are the communication styles proposed by Tannenbaum and Schmidt? Please choose one style, suggest in what situations it is appropriate and give an example. (From Communication)
2. Many companies fall. Big names are Enron, WorldCom, Kmart, Polaroid, Xerox etc. According to statistics, the four year survival rate of start-ups is as low as 29%. Therefore, why shall entrepreneurs start numerous new businesses every year? Please give at least 3 causes and explain what entrepreneurship is. (From The Entrepreneurial Profile)
3. A selfie stick is a monopod used to take selfie photographs by positioning a smartphone or camera beyond the normal range of the arm. The metal sticks are typically extensible, with a handle on one end and an adjustable clamp on the other end to hold a phone in place.Some have remote or Bluetooth controls, letting the user decide when to take the picture. The product was listed in Time magazine's 25 best inventions of 201
4.The selfie stick is an essential carry-on item for many travellers. On departure, people took selfies. On the plane there were selfies at 32,000 meters. In most cases, the appeal seems to be simply fitting more people into the frame. How would you do the marketing of selfie sticks? Give at least 2 points and justify. (Marketing)
4. Mr Richard was an office director. He rarely went out into the main body of the office. He preferred to work in his room on the other side of the corridor and asked Miss Joan, the deputy director, to sit in a corner of the main office and be his ‘eyes and ears’. As a result, all the staffs were wary of Miss Joan. They were polite, but guarded in their responses whenever she spoke to them. Give comments on the leadership situation and/or suggestions. Please justify. (From Organizational Behavior)
II. Vocabulary Choice (20%)
Directions: In this section, there is a passage with blanks. Choose the right words from the box given below to fill in the blanks. One word can be used only once. Make changes where necessary.
share right lever demand include firm
high basis move finance leave environment
The International Business Environment
The following considers some of the important aspects of the business environment that change internationally.
The economic environment can be very different from one nation to another. Countries are often divided into three main categories: the more developed or industrialized, the less developed or third world, and the newly industrializing or emerging economies. Within each category there are major variations, but overall the more developed countries are the rich countries, the less developed the poor ones, and the newly industrializing (those
moving from poorer to richer). These distinctions are usually made on the __________ (1) of gross domestic product per capita (GDP/capita). Better education, infrastructure, technology, health care, and so on are also often associated with higher levels of economic development.
In addition to level of economic development, countries can be classified as free-market, centrally planned, or mixed. Free-market economies are those where government intervenes minimally in business activities, and market forces of supply and
_____________ (2)are allowed to determine production and prices. Centrally planned economies are those where the government determines production and prices based on forecasts of demand and desired levels of supply. Mixed economies are those where some
activities are _____________ (3) to market forces and some, for national and individual welfare reasons, are government controlled. In the late twentieth century there has been a substantial _____________ (4)to free-market economies, but the People's Republic of China, the world's most populous country, along with a few others, remained largely centrally planned economies, and most countries maintain some government control of business activities.
The cultural environment is one of the critical components of the international business
___________ (5) and one of the most difficult to understand. This is because the cultural environment is essentially unseen; it has been described as a shared, commonly held body of general beliefs and values that determine what is ___________ (6)for one group,
according to Kluckhohn and Strodtbeck. National culture is described as the body of general beliefs and values that are ___________ (7) by a nation. Beliefs and values are generally seen as formed by factors such as history, language, religion, geographic location, government, and education; thus firms begin a cultural analysis by seeking to understand these factors.
___________ (8)want to understand what beliefs and values they may find in countries where they do business, and a number of models of cultural values have been proposed by scholars. The most well-known is that developed by Hofstede in1980. This
model proposes four dimensions of cultural values ___________ (9)individualism, uncertainty avoidance, power distance and masculinity. This model of cultural values has been used extensively because it provides data for a wide array of countries. Many academics and managers found this model helpful in exploring management approaches that would be appropriate in different cultures. For example, in a nation that is
___________ (10)on individualism one expects individual goals, individual tasks, and individual reward systems to be effective, whereas the reverse would be the case in a nation that is low on individualism.
III. Case Analysis (40%)
Directions: Please first read the case below, answer the questions after the passage, and then write a case study report in accordance with the following pattern.
I. Define and analyze the problem.
II. Suggest possible solutions.
III. Evaluate possible solutions.
IV. Select a solution.
The case:
What are the financing options for ACT?
Advanced Cell Technology (ACT), a biotechnology company based in Marlborough, Massachusetts, has long flirted with fame — and bankruptcy.
The company is running the only Food and Drug Administration (FDA)-approved clinical trials (临床试验) of embryonic stem (ES)-cell therapies(胚胎干细胞治疗法). Later this month, ACT plans to report preliminary results （初步结果）from three trials to test the safety of its treatment for two different forms of vision loss. If all goes well, it could be the first clinical demonstration of the safety — and perhaps also the therapeutic potential — of ES cells.
Yet a series of financial missteps （失策）could cost ACT the opportunity to see that potential become reality. On 22 January, the firm announced that its chief executive, Gary Rabin, was stepping down. The news came a month after ACT—which had $5.5 million in cash on-hand as of 30 September 2014 — announced that it would pay $4 million to settle a Securities and Exchange Commission (SEC) charge （指控）alleging that the company had illegally sold billions of shares of stock.
“That’s a big hit for any biotechnology company,” says Gregory Bonfiglio, a venture capitalist with Proteus Venture Partners in Portola Valley, Calif. “This is a very painful t ime for them.”
ACT is accustomed to the pain: it has been running on fumes for years and has repeatedly skirted （濒临）bankruptcy. The company announced this week that it aims to begin the next round of its clinical trials in the second half of 2015. But its last quarterly statement, which covered the period ending September 30, revealed that the company had only enough funds to last into the second half of 2015.ACT spokesman David Schull says that the firm is exploring all financing options and plans to expand its clinical operations to accommodate the upcoming trials.
That financing may have to carry ACT through additional legal charges. The settlement with the Securities and Exchange Commission was just one of a string of cases ACT has handled over the past few years as it dealt with the legacy left by the fundraising schemes of its previous chief executive, William Caldwell. One such case is still pending, and the SEC has launched a separate investigation of Rabin for distributing stock without reporting it to the SEC “in a timely fashion."
More recently, on January 2, the Wisconsin Alumni Research Foundation (WARF) sued ACT for breach of contract（违反合同）. WARF, which handles patents and licensing for the University of Wisconsin, holds a number of key ES-cell patents, and ACT struck a licensing deal with the foundation in 2007. The case has been sealed, and lawyers representing WARF did not respond immediately to requests for comment.
Other trials under way
ACT may soon have company in the clinic. The London Project to Cure Blindness has been developing an ES cell‒derived therapy to treat age-related macular degeneration （黄斑变性）, a leading form of vision loss in people aged 50 and older.
The project has gotten regulatory approval and the team is preparing cells for the trial, says a spokesman for Pfizer, the New York-based pharmaceutical giant that is backing the project.
Another trial, announced last year and led by ophthalmologist （眼科医师）Masayo Takahashi of the RIKEN Center for Developmental Biology in Kobe, Japan, will use adult cells reprogrammed to take on an ES cell‒like state. These cells, called induced pluripotent stem cells（多能肝细胞）, have less of a risk of provoking an immune response because they can be derived from the patient’s own tissue.
Both Takahashi’s trial and the London effort have an advantage over ACT’s approach,
says Stephen Rose, chief research officer of the Foundation Fighting Blindness in Columbia, Md. All three trials aim to protect cells that make up a sheet over the retina （视网膜）. ACT’s trial injects a bolus of such cells, called retinal pigment epithelium cells（视网膜色素上皮细胞）, into the eye. The other two groups have found ways to grow the cells and transplant them in sheets, more closely mimicking their natural state.
But Rose still hopes that ACT will be able to finish its trials, and says that the data on immune responses （免疫反应）to the therapy will be invaluable. In the meantime, he is optimistic about what the year holds for the field. “These trials are going to be popping up like weeds,” says Rose. “It’s a very exciting time.”
Questions:
1. What was ACT charged with by SEC?
2. What financing problem faces ACT?
3. How was WARF related to ACT?
4. Why doesn’t ACT fall? Give two points at least.
A Case Study Report。